Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders Growth (5y) (2015 - 2025)
Analysis
Xtant Medical Holdings (XTNT) Net Income towards Common Stockholders Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Xtant Medical Holdings | 47.61 Mn | 30.01 Mn | 17.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -43.65% |
| Sep 30, 2025 | 24.25% |
| Jun 30, 2025 | 28.04% |
| Mar 31, 2025 | 15.14% |
| Dec 31, 2024 | -78.07% |
| Sep 30, 2024 | -21.74% |
| Jun 30, 2024 | -14.77% |
| Mar 31, 2024 | -9.47% |
| Dec 31, 2023 | 40.29% |
| Sep 30, 2023 | 37.57% |
| Jun 30, 2023 | 15.23% |
| Mar 31, 2023 | 16.93% |
| Dec 31, 2022 | 57.96% |
| Sep 30, 2022 | 22.64% |
| Jun 30, 2022 | 29.30% |
| Mar 31, 2022 | 17.99% |
| Dec 31, 2021 | 22.22% |
| Sep 30, 2021 | 18.66% |
| Jun 30, 2021 | 32.17% |
| Mar 31, 2021 | 64.56% |